HE OLVIDADO MI CONTRASEÑA
Indique su correo electrónico,
recibirá un link para cambiar su contraseña.

ENVIAR
CANCELAR
ACCESO AL ÁREA DE SOCIOS
Usuario:
Contraseña:
Recuérdame
ACCEDER
He olvidado mi contraseña
CREAR NUEVA CARPETA

Nombre de la carpeta:
CREAR
CANCELAR
RENOMBRAR CARPETA
Selecciona y renombra la carpeta que deseas modificar.

Nombre de la carpeta:
RENOMBRAR
CANCELAR
ELIMINAR CARPETA
Selecciona las carpetas que desea eliminar.
Tenga en cuenta que el contenido
de la carpeta no se podrá recuperar.

ELIMINAR
CANCELAR
BORRAR DOCUMENTO
¿Estás seguro que deseas
BORRAR el documento
selecionado?.

Una vez borrado el documento
ya no se podrá recuperar.
BORRAR
CANCELAR
VALIDAR DOCUMENTO
El documento sera validado


VALIDAR
CANCELAR
ENVIAR NOTIFICACIÓN

Se enviara una notificación
sobre este documento a los socios.



Se trata de una convocatoria con fecha:
ENVIAR
CANCELAR
AGREGAR DOCUMENTO
Seleccione el documento que desea agregar.



Enviar notificación a los Socios del documento agregado
Se trata de una convocatoria con fecha:
El documento se ubicara primeramente en el área de validación
AGREGAR
CANCELAR
CONTACTAR ADMINISTRADOR
Envíale un correo a los administradores


ENVIAR
CANCELAR
AVISO

Mensaje de aviso
ACEPTAR
CONVOCATORIA
archivo_de_la_convocatoria.pdf
descargar
ver
FORMULARIO DE ASISTENCIA
SÍ, asistiré       NO, pero delego mi voto       NO, y no delego mi voto                  
enviar

Training

CARDIOVASCULAR

SCORE SCALE FOR CARDIOVASCULAR RISK

The SCORE scale makes it possible to estimate the 10-year risk of the first lethal atherosclerotic complication (acute myocardial infarction, cerebrovascular accident, peripheral arterial complication or sudden death) based on the following risk factors: age, sex, smoking, systolic blood pressure and total cholesterol. Different tables are available for the European regions of high and low risk and, of course, for both sexes; there are also adaptations for different countries, including Spain.

CONTROVERSIES AND COMORBIDITIES IN HYPERTENSION

There are several controversies arising from the high morbidity and mortality suffered by patients with hypertension. In this review, we discuss the main one today, which is to mark the target blood pressure for the population suffering from hypertension. Accordingly, we address other controversies, such as the modification of the prognosis of these patients, the best therapeutic option, the need for a correct diagnosis and the necessary individualisation of each case.

THERVAN QUESTIONS AND ANSWERS

NEW GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDEMIAS

The new guidelines for the management of dyslipidemias issued by the European Society of Cardiology are a milestone with regard to the importance they give to a significant reduction in LDL cholesterol levels.

From a practical point of view, their main messages can be summed up in three questions (WHAT? WHY? HOW?) and their respective answers.

IMPLICACIONES CARDIOVASCULARES DEL SARS-COV2

In this paper, Dr Prieto Merino explains the implications and cardiovascular complications of SARS-COV2 and the medications used to treat it.
This book will also show how it has affected patients with underlying conditions, as well as patients who, despite not having contracted the disease, have been forced into lockdown.

Implicaciones cardiovasculares del SARS-COV2

Implicaciones postcovid